Special Issue "Primary Intraocular Tumors–Molecular Mechanisms, Novel Therapeutic Strategies and Targets"
Deadline for manuscript submissions: 31 January 2022.
Interests: chemoresistance; extracellular matrix; molecular signaling; retinoblastoma; tumor niche microenvironment; therapeutic options; tumor stem cells
Primary intraocular tumors, such as retinoblastoma, uveal melanoma, and primary vitreoretinal lymphoma, are an indescribable burden for patients by threatening sight and survival at the same time. Most likely local tumor control/metastasis prevention, eye salvage, and sight preservation are common objectives in these cancers. In order to improve the care of patients, this Special Issue invites authors to submit comprehensive molecular biological work regarding possible future improvements in diagnostics or/and therapy, displaying up-to-date knowledge and application thereof. Experts in the field will be invited to present their research, which will provide new insights into the current state of inter alia molecular patho- and signaling mechanisms, the identification of novel molecular biomarkers, and innovative targeted therapeutic options.
Dr. Jacqueline Reinhard
Dr. Vinodh Kakkassery
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Animal/cell culture models
- Intraocular tumors
- Molecular signaling
- Therapy approaches
- Uveal melanoma
- Vitreoretinal lymphoma